PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.685
+0.012 (1.83%)
At close: Mar 9, 2026, 4:00 PM EDT
0.685
-0.000 (-0.01%)
After-hours: Mar 9, 2026, 4:00 PM EDT
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $37.50 million as of March 9, 2026. Its market cap has decreased by -29.42% in one year.
Market Cap
37.50M
Enterprise Value
28.59M
1-Year Change
-29.42%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has decreased from $45.51M to $37.50M, a decrease of -17.62%. That is a compound annual growth rate of -2.74%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xilio Therapeutics | 38.93M |
| Jasper Therapeutics | 38.62M |
| CervoMed | 38.03M |
| Sensei Biotherapeutics | 37.96M |
| Actinium Pharmaceuticals | 37.44M |
| Atara Biotherapeutics | 37.28M |
| Lisata Therapeutics | 36.87M |
| Tvardi Therapeutics | 36.87M |